Magnetar Financial’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Magnetar Financial’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-713,357	Closed	-$71.3K	–	997
2024 Q4	$71.3K	Buy	+713,357	New	+$36.4K	﹤0.01%	580
2022 Q4	–	Sell	-200,000	Closed	-$29K	–	1002
2022 Q3	$29K	Buy	200,000 +183,880	+1,141%	+$31.6K	﹤0.01%	1015
2022 Q2	$4	Buy	+16,120	New	+$6.38K	﹤0.01%	1526

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Magnetar Financial's NKGNW Position: Q1 2025 in Review

Magnetar Financial sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 713,357 shares — an estimated $71.3K sold.

Magnetar Financial first reported a position in NKGNW in Q2 2022 and held it in 3 quarters. The position peaked at $71.3K in Q4 2024. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Magnetar Financial reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Magnetar Financial sold 713,357 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $71.3K.
Magnetar Financial first reported a position in NKGen Biotech, Inc. Warrants in Q2 2022 and held it in 3 quarters.
Magnetar Financial's NKGen Biotech, Inc. Warrants position peaked at $71.3K in Q4 2024.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.